| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Frequent EpCam protein expression in human carcinomas.
|
Hum Pathol
|
2004
|
4.94
|
|
2
|
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
|
J Pathol
|
2014
|
3.21
|
|
3
|
Cancer classification using the Immunoscore: a worldwide task force.
|
J Transl Med
|
2012
|
2.88
|
|
4
|
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
|
Nat Genet
|
2004
|
2.44
|
|
5
|
Prevalence of KIT expression in human tumors.
|
J Clin Oncol
|
2004
|
2.40
|
|
6
|
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
|
J Clin Pathol
|
2006
|
2.17
|
|
7
|
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
|
Int J Cancer
|
2010
|
2.08
|
|
8
|
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
|
Int J Cancer
|
2010
|
1.96
|
|
9
|
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
|
Oncotarget
|
2010
|
1.88
|
|
10
|
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
|
Int J Cancer
|
2010
|
1.41
|
|
11
|
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
|
Mod Pathol
|
2012
|
1.38
|
|
12
|
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
|
J Transl Med
|
2013
|
1.31
|
|
13
|
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
|
J Pathol
|
2011
|
1.24
|
|
14
|
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
|
Clin Cancer Res
|
2008
|
1.23
|
|
15
|
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
|
Am J Clin Pathol
|
2007
|
1.22
|
|
16
|
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
|
Hum Pathol
|
2011
|
1.18
|
|
17
|
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
|
World J Gastroenterol
|
2009
|
1.17
|
|
18
|
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
|
Int J Cancer
|
2010
|
1.16
|
|
19
|
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
|
Int J Cancer
|
2010
|
1.16
|
|
20
|
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.
|
Eur J Cancer
|
2010
|
1.15
|
|
21
|
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
|
Mod Pathol
|
2007
|
1.13
|
|
22
|
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
|
Cancer
|
2008
|
1.12
|
|
23
|
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
|
Eur J Cancer
|
2007
|
1.10
|
|
24
|
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
|
Hum Pathol
|
2012
|
1.10
|
|
25
|
Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.
|
Histopathology
|
2012
|
1.05
|
|
26
|
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
|
J Transl Med
|
2013
|
1.04
|
|
27
|
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.
|
Mod Pathol
|
2007
|
1.04
|
|
28
|
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
|
Clin Cancer Res
|
2008
|
1.04
|
|
29
|
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
|
Mod Pathol
|
2003
|
1.03
|
|
30
|
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
|
Clin Cancer Res
|
2008
|
1.02
|
|
31
|
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
|
Int J Cancer
|
2013
|
1.02
|
|
32
|
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
|
Mod Pathol
|
2006
|
1.01
|
|
33
|
Patterns of gene amplification in gastrointestinal stromal tumors (GIST).
|
Lab Invest
|
2005
|
0.99
|
|
34
|
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
|
PLoS One
|
2013
|
0.97
|
|
35
|
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
|
Mod Pathol
|
2012
|
0.97
|
|
36
|
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
|
Histopathology
|
2011
|
0.97
|
|
37
|
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
|
Eur J Cancer
|
2007
|
0.96
|
|
38
|
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
|
Histopathology
|
2009
|
0.95
|
|
39
|
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
|
PLoS One
|
2010
|
0.95
|
|
40
|
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
|
Histopathology
|
2013
|
0.94
|
|
41
|
The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
|
Histopathology
|
2012
|
0.94
|
|
42
|
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
|
Head Neck
|
2011
|
0.93
|
|
43
|
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
|
World J Gastroenterol
|
2010
|
0.93
|
|
44
|
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.
|
J Transl Med
|
2014
|
0.93
|
|
45
|
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
|
World J Gastroenterol
|
2010
|
0.91
|
|
46
|
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.
|
Virchows Arch
|
2007
|
0.91
|
|
47
|
Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
|
Hum Pathol
|
2008
|
0.90
|
|
48
|
Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
|
Hum Pathol
|
2009
|
0.90
|
|
49
|
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
|
Histopathology
|
2010
|
0.90
|
|
50
|
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
|
J Pathol
|
2003
|
0.88
|
|
51
|
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.
|
Virchows Arch
|
2015
|
0.88
|
|
52
|
Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.
|
J Transl Med
|
2012
|
0.88
|
|
53
|
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
|
Cancer
|
2009
|
0.87
|
|
54
|
VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
|
Mod Pathol
|
2011
|
0.86
|
|
55
|
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
|
Am J Clin Pathol
|
2007
|
0.85
|
|
56
|
Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.
|
Virchows Arch
|
2014
|
0.85
|
|
57
|
Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.
|
Front Oncol
|
2012
|
0.84
|
|
58
|
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer.
|
Front Oncol
|
2013
|
0.84
|
|
59
|
Metastases and primary tumors around dental implants: A literature review and case report of peri-implant pulmonary metastasis.
|
Quintessence Int
|
2012
|
0.83
|
|
60
|
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
|
Cancer
|
2010
|
0.82
|
|
61
|
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach.
|
Hum Pathol
|
2008
|
0.82
|
|
62
|
Role of tumor size in the pre-operative management of rectal cancer patients.
|
BMC Gastroenterol
|
2010
|
0.81
|
|
63
|
Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
|
Virchows Arch
|
2014
|
0.79
|
|
64
|
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
|
BMC Cancer
|
2010
|
0.79
|
|
65
|
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.
|
Oncotarget
|
2014
|
0.79
|
|
66
|
Construction and validation of a bone marrow tissue microarray.
|
J Clin Pathol
|
2006
|
0.79
|
|
67
|
Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
|
Dis Colon Rectum
|
2009
|
0.78
|
|
68
|
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.
|
Int J Surg Oncol
|
2012
|
0.77
|
|
69
|
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).
|
J Transl Med
|
2013
|
0.77
|
|
70
|
Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.
|
Histopathology
|
2014
|
0.76
|
|
71
|
Standardization of whole slide image morphologic assessment with definition of a new application: Digital slide dynamic morphometry.
|
J Pathol Inform
|
2011
|
0.75
|
|
72
|
Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells.
|
Oncotarget
|
2017
|
0.75
|